<table id="i22d4afbb-fc2d-48dd-85a9-fdbc59a84b7e" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 4. Effect of Atorvastatin on the Pharmacokinetics of 
Co-administered Drugs</caption>
<col align="left" valign="top" width="25%"></col>
<col align="left" valign="top" width="25%"></col>
<col align="left" valign="top" width="25%"></col>
<col align="left" valign="top" width="25%"></col>
<thead>
<tr>
<th>Atorvastatin</th>
<th colspan="3">Co-administered drug and dosing 
regimen</th>
</tr>
<tr>
<th>
<br/>
</th>
<th>Drug/Dose (mg)</th>
<th>Change in AUC</th>
<th>Change in Cmax</th>
</tr>
</thead>
<tbody>
<tr>
<td>80 mg QD for 15 days </td>
<td>Antipyrine, 600 mg SD</td>
<td>↑ 3%</td>
<td>↓ 11%</td>
</tr>
<tr>
<td>80 mg QD for 14 days</td>
<td>
<linkhtml href="#footnote-7">*</linkhtml> Digoxin 0.25 mg QD, 20 days</td>
<td>↑ 15%</td>
<td>↑ 20 %</td>
</tr>
<tr>
<td>40 mg QD for 22 days </td>
<td>Oral contraceptive QD, 2 months<br/>- norethindrone 
1mg<br/>- ethinyl estradiol 35µg</td>
<td>
<br/>↑ 28%<br/>↑ 19%</td>
<td>
<br/>↑ 23%<br/>↑ 30%</td>
</tr>
</tbody>
</table>